-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PJx3MMbbDqYiCOvPWvmKMg1F+q9hJiP2L6TwyUiQUl8EYEUoLMgCmSSi7MfCeW4w ywo1bTBm3r+m97iwMxHuEg== 0000902664-07-002630.txt : 20070814 0000902664-07-002630.hdr.sgml : 20070814 20070814165108 ACCESSION NUMBER: 0000902664-07-002630 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20070810 FILED AS OF DATE: 20070814 DATE AS OF CHANGE: 20070814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NOVEN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000815838 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 592767632 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11960 SW 144TH ST CITY: MIAMI STATE: FL ZIP: 33186 BUSINESS PHONE: 3052535099 MAIL ADDRESS: STREET 1: 11960 SW 144TH STREET CITY: MIAMI STATE: FL ZIP: 33185 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: OSS CAPITAL MANAGEMENT CENTRAL INDEX KEY: 0001218321 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17254 FILM NUMBER: 071056207 MAIL ADDRESS: STREET 1: 605 THIRD AVE CITY: NEW YORK STATE: NY ZIP: 10158 4 1 form4_ex.xml X0202 4 2007-08-10 0 0000815838 NOVEN PHARMACEUTICALS INC NOVN 0001218321 OSS CAPITAL MANAGEMENT 598 MADISON AVE NEW YORK NY 10022 0 0 1 0 Common Stock ($.0001 par value) 2007-08-10 4 P 0 15000 16.78 A 2706690 I See Footnote This Form 4 is being filed to report that O.S.S. Capital Management LP, a Delaware limited partnership (the "Investment Manager"), Schafer Brothers LLC, a Delaware limited liability company (the "SB LLC") and Mr. Oscar S. Schafer ("Mr. Schafer", collectively with the Investment Manager and SB LLC, the "Reporting Persons") have purchased an additional 15,000 shares of Noven Pharmaceuticals Inc. (the "Issuer") common shares. The Reporting Persons have investment discretion with respect to securities held by a Cayman Islands exempted company and two Delaware limited partnerships as more fully described in the Form 3 filed on July 16, 2007 (Accession Number: 0000902664-07-002296) and the Form 4 filed on August 8, 2007 (Accession Number: 0000902664-07-002474). Each of the Investment Manager, SB LLC and Mr. Schafer may be deemed to beneficially own 2,706,690 shares of common stock, which represent, together, approximately 10.9% of the outstanding shares of common stock. Each of the Investment Manager, SB LLC, and Mr. Schafer disclaims beneficial ownership of the securities included in this report and this report shall not be deemed an admission that either the Investment Manager, SB LLC, or Mr. Schafer is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. This report shall not be deemed an admission that the Reporting Persons are or have been the beneficial owners of such securities for purposes of Section 16 or for any other purpose. /s/ Oscar S. Schafer 2007-08-14 EX-99 2 jtfiler.txt JOINT FILER INFORMATION EXHIBIT 99 FORM 4 JOINT FILER INFORMATION Name: Schafer Brothers LLC Address: 598 Madison Avenue New York, NY 10022 Designated Filer: O.S.S. Capital Management LP Issuer and Ticker Symbol: Noven Pharmaceuticals Inc. [ NOVN ] Date of Event requiring statement: August 10, 2007 /s/ Oscar S. Schafer - ------------------------------- Signature FORM 4 JOINT FILER INFORMATION Name: Mr. Oscar S. Schafer Address: 598 Madison Avenue New York, NY 10022 Designated Filer: O.S.S. Capital Management LP Issuer and Ticker Symbol: Noven Pharmaceuticals Inc. [ NOVN ] Date of Event requiring statement: August 10, 2007 /s/ Oscar S. Schafer - ------------------------------- Signature -----END PRIVACY-ENHANCED MESSAGE-----